Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 23478-25-3 | MDL No. : | MFCD00522625 |
Formula : | C15H13NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | IIFFDQOHESPFOL-MDZDMXLPSA-N |
M.W : | 239.27 g/mol | Pubchem ID : | 721434 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 72.39 |
TPSA : | 49.33 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.45 cm/s |
Log Po/w (iLOGP) : | 2.11 |
Log Po/w (XLOGP3) : | 3.25 |
Log Po/w (WLOGP) : | 2.74 |
Log Po/w (MLOGP) : | 2.57 |
Log Po/w (SILICOS-IT) : | 2.66 |
Consensus Log Po/w : | 2.67 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.6 |
Solubility : | 0.0601 mg/ml ; 0.000251 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.96 |
Solubility : | 0.0263 mg/ml ; 0.00011 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.44 |
Solubility : | 0.00877 mg/ml ; 0.0000366 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.19 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 127033-74-3 ]
N-(3-Methoxyphenyl)cinnamamide
Similarity: 0.93
[ 16375-90-9 ]
N-(4-hydroxy-3-methylphenyl)acetamide
Similarity: 0.89
[ 16375-88-5 ]
N-(4-(Hydroxymethyl)phenyl)acetamide
Similarity: 0.80
[ 127033-74-3 ]
N-(3-Methoxyphenyl)cinnamamide
Similarity: 0.93
[ 133550-35-3 ]
(E)-2-Cyano-3-(3,4-dihydroxyphenyl)-N-phenylacrylamide
Similarity: 0.76
[ 103188-46-1 ]
(E)-N-(3,4-Dihydroxyphenethyl)-3-(4-hydroxyphenyl)acrylamide
Similarity: 0.70
[ 1552-96-1 ]
4-(Dimethylamino)cinnamic Acid
Similarity: 0.68
[ 127033-74-3 ]
N-(3-Methoxyphenyl)cinnamamide
Similarity: 0.93
[ 16375-90-9 ]
N-(4-hydroxy-3-methylphenyl)acetamide
Similarity: 0.89
[ 127033-74-3 ]
N-(3-Methoxyphenyl)cinnamamide
Similarity: 0.93
[ 16375-90-9 ]
N-(4-hydroxy-3-methylphenyl)acetamide
Similarity: 0.89
[ 16375-88-5 ]
N-(4-(Hydroxymethyl)phenyl)acetamide
Similarity: 0.80